Core Insights - David Mountcastle, EVP & CFO of Privia Health Group, sold 13,018 shares for approximately $283,000, primarily to cover tax obligations related to the vesting of performance stock units [1][7]. Transaction Summary - The direct sale involved 13,018 shares with a total transaction value of $283,000 [2]. - Post-transaction, Mountcastle holds 226,804 direct shares and 8,695 indirect shares, with a direct ownership stake of 0.18% of the company's outstanding shares [5][2]. Company Overview - Privia Health Group has a market capitalization of $2.61 billion and reported a revenue of $2.12 billion with a net income of $22.92 million for the trailing twelve months [4]. - The company's stock price has decreased by 10.15% over the past year as of March 21, 2026 [4]. Financial Performance - In Q4 FY 2025, Privia exceeded earnings expectations, reporting earnings of 7 cents per share, surpassing the 4-cent estimate and marking the highest year-over-year growth since Q3 2023 [8]. Growth Strategy - Privia is optimistic about its growth in value-based operations following the acquisition of an Accountable Care Organization (ACO) in late September 2025, which added approximately 1.5 million customers with various medical plans [9].